[HTML][HTML] Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
H Li, N Huang, W Zhu, J Wu, X Yang, W Teng, J Tian… - BMC cancer, 2018 - Springer
Abstract Background Tumor-associated macrophages (TAMs) play a critical role in
modulating the tumor microenvironment and promote tumor metastases. Our studies have …
modulating the tumor microenvironment and promote tumor metastases. Our studies have …
[HTML][HTML] Role of ginsenoside Rh2 in tumor therapy and tumor microenvironment immunomodulation
S Xiaodan, C Ying - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Ginsenoside Rh2 (Rh2), the major bio-active ginsenoside that originated from the
root of Panax ginseng, has become a “hot topic” for playing multifunctional roles in both …
root of Panax ginseng, has become a “hot topic” for playing multifunctional roles in both …
[HTML][HTML] Ginsenosides Rk1 and Rg5 inhibit transforming growth factor-β1-induced epithelial-mesenchymal transition and suppress migration, invasion, anoikis …
H Kim, P Choi, T Kim, Y Kim, BG Song, YT Park… - Journal of ginseng …, 2021 - Elsevier
Background Lung cancer has a high incidence worldwide, and most lung cancer-associated
deaths are attributable to cancer metastasis. Although several medicinal properties of Panax …
deaths are attributable to cancer metastasis. Although several medicinal properties of Panax …
[HTML][HTML] Ginsenoside Rg3 inhibits epithelial-mesenchymal transition (EMT) and invasion of lung cancer by down-regulating FUT4
L Tian, D Shen, X Li, X Shan, X Wang, Q Yan, J Liu - Oncotarget, 2016 - ncbi.nlm.nih.gov
The epithelial-mesenchymal transition (EMT) is an important factor in lung cancer
metastasis, and targeting EMT is a potential therapeutic strategy. Fucosyltransferase IV …
metastasis, and targeting EMT is a potential therapeutic strategy. Fucosyltransferase IV …
[HTML][HTML] Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo
YC Tang, Y Zhang, J Zhou, Q Zhi… - International …, 2018 - spandidos-publications.com
Anti-angiogenic therapy has been successfully applied to treat colorectal cancer (CRC).
Ginsenoside Rg3, derived from the Chinese herb ginseng, has anti-vascularization effects …
Ginsenoside Rg3, derived from the Chinese herb ginseng, has anti-vascularization effects …
Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial–mesenchymal transition and stemness
J Wang, L Tian, MN Khan, L Zhang, Q Chen, Y Zhao… - Cancer Letters, 2018 - Elsevier
Cisplatin is a first line chemotherapy in lung cancer, but decreased susceptibility may limit its
application. In solid tumors, hypoxia alters the microenvironment and is associated with …
application. In solid tumors, hypoxia alters the microenvironment and is associated with …
[HTML][HTML] Strategies for remodeling the tumor microenvironment using active ingredients of Ginseng—a promising approach for cancer therapy
M Li, X Wang, Y Wang, S Bao, Q Chang, L Liu… - Frontiers in …, 2021 - frontiersin.org
The tumor microenvironment (TME) plays a key role in promoting the initiation and
progression of tumors, leading to chemoradiotherapy resistance and immunotherapy failure …
progression of tumors, leading to chemoradiotherapy resistance and immunotherapy failure …
Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells
JW Kim, SY Jung, YH Kwon, JH Lee… - Cancer biology & …, 2012 - Taylor & Francis
Accumulating evidence suggests that Ginsenoside Rg3 appears to inhibit tumor growth
including Lewis lung carcinoma, intestinal adenocarcinomas or B16 melanoma by inhibiting …
including Lewis lung carcinoma, intestinal adenocarcinomas or B16 melanoma by inhibiting …
Ginsenoside Rh2 improves the cisplatin anti-tumor effect in lung adenocarcinoma A549 cells via superoxide and PD-L1
Y Chen, Y Zhang, W Song, Y Zhang… - Anti-Cancer Agents in …, 2020 - ingentaconnect.com
Background: Ginsenoside Rh2 (Rh2) is a major biological component of ginseng that exerts
antitumor activities in multiple cancers including Non-Small Cell Lung Cancers (NSCLCs) …
antitumor activities in multiple cancers including Non-Small Cell Lung Cancers (NSCLCs) …
Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial–mesenchymal transition and suppresses lung cancer migration, invasion and anoikis …
The epithelial–mesenchymal transition (EMT) is a pivotal cellular process during which
epithelial polarized cells become motile mesenchymal-appearing cells, which, in turn …
epithelial polarized cells become motile mesenchymal-appearing cells, which, in turn …
相关搜索
- tumor angiogenesis ginsenoside rg3
- tumor migration ginsenoside rh2
- ginsenosides rk1 lung cancer
- cancer progression ginsenoside rg3
- cancer progression tumor angiogenesis
- pd l1 ginsenoside rh2
- progenitor cells ginsenoside rg3
- progenitor cells tumor angiogenesis
- lung cancer anoikis resistance
- tumor microenvironment ginsenoside rh2
- tumor therapy ginsenoside rh2
- lung cancer ginsenoside rg3